Copyright © 2001 by the European Society of Cardiology.
Hotline Editorials
Randomized trial of rhythm or rate control in atrial fibrillation: the Pharmacological Intervention in Atrial Fibrillation Trial (PIAF)
PIAF trial investigators
References
- Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994;271:840844
[Abstract/Free Full Text] - Psaty BM, Manolio TA, Kuller LH. Incidence of and risk factors for atrial fibrillation in older adults. Circulation. 1997;96:24552461
[Abstract/Free Full Text] - Prystowski EN. Management of atrial fibrillation: therapeutic options and clinical decisions. Am J Cardiol. 2000;85:3D11D[Web of Science][Medline]
- Arch Intern Med. 1994;154:14491457
[Abstract/Free Full Text] - Hohnloser SH, Kuck KH, Lilienthal J. Rhythm versus rate control in atrial fibrillationPharmacological intervention in atrial fibrillation (PIAF): a randomised trial. Lancet. 2000;356:17891794[CrossRef][Web of Science][Medline]
- Bhandari AK, Anderson JL, Gilbert EM. Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: a transtelephonic monitoring study. Am Heart J. 1992;124:381386[CrossRef][Web of Science][Medline]
- Prystowsky EN, Margiotti R, Fogel R, Evans JJ, Freedberg N, Shaar C. Atrial fibrillation with and without heart disease: clinical characteristics and proarrhythmia risk (Abstr). Circulation. 1996;94:I-191
- Levy S, Marek M, Coumel P. on behalf of the French Cardiologists. Characterization of different subsets of atrial fibrillation in general practice in France. The ALFA study. Circulation. 1999;99:30283035
[Abstract/Free Full Text] - Brignole M, Menozzi C, Gianfranchi L. Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation. A randomized controlled study. Circulation. 1998;98:953960
[Abstract/Free Full Text] - Lee S, Chen A, Tai C. Comparisons of quality of life and cardiac performance after complete atrioventricular junction ablation and atrioventricular modification in patients with medically refractory atrial fibrillation. J Am Coll Cardiol. 1998;31:637644
[Abstract/Free Full Text] - Gosselink ATM, Crijns HJGM, van den Berg MP. Functional capacity before and after cardioversion of atrial fibrillation: a controlled study. Br Heart J. 1994;72:161166
[Abstract/Free Full Text] - Am J Cardiol. 1997;79:11981202[CrossRef][Web of Science][Medline]
- Circulation. 2000;102:II-671
This article has been cited by other articles:
![]() |
E. Anter and D. J. Callans Pharmacological and Electrical Conversion of Atrial Fibrillation to Sinus Rhythm Is Worth the Effort Circulation, October 6, 2009; 120(14): 1436 - 1443. [Full Text] [PDF] |
||||
![]() |
M C S Hall and D M Todd Modern management of arrhythmias Postgrad. Med. J., February 1, 2006; 82(964): 117 - 125. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. P. Gerstenfeld Does Rhythm Control Improve Functional Status in Patients With Atrial Fibrillation? J. Am. Coll. Cardiol., November 15, 2005; 46(10): 1900 - 1901. [Full Text] [PDF] |
||||
![]() |
O. M. Wazni, N. F. Marrouche, D. O. Martin, A. Verma, M. Bhargava, W. Saliba, D. Bash, R. Schweikert, J. Brachmann, J. Gunther, et al. Radiofrequency Ablation vs Antiarrhythmic Drugs as First-line Treatment of Symptomatic Atrial Fibrillation: A Randomized Trial JAMA, June 1, 2005; 293(21): 2634 - 2640. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Golovchiner, A. Mazur, A. Kogan, B. Strasberg, Y. Shapira, M. Fridman, J. Kuzniec, B. A. Vidne, and E. Raanani Atrial Flutter After Surgical Radiofrequency Ablation of the Left Atrium for Atrial Fibrillation Ann. Thorac. Surg., January 1, 2005; 79(1): 108 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Dorian, I. Mangat, A. Pinter, and V. Korley The Burden of Atrial Fibrillation: Should We Abandon Antiarrhythmic Drug Therapy? Journal of Cardiovascular Pharmacology and Therapeutics, October 1, 2004; 9(4): 257 - 262. [Abstract] [PDF] |
||||
![]() |
K. H. Humphries, C. R. Kerr, M. Steinbuch, P. Dorian, and for The Canadian Registry of Atrial Fibrillation Limitations to antiarrhythmic drug use in patients with atrial fibrillation Can. Med. Assoc. J., September 28, 2004; 171(7): 741 - 745. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






